— Sarepta Therapuetics soared more than 15% on Friday after a potential competitor drug from Pfizer showed side effects in a study. Pfizer has paused the study of its new drug to treat Duchenne muscular dystrophy after two of the participants in a small trial were hospitalized.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Stocks making the biggest moves after hours: Rite Aid, Herman Miller and moreSee which stocks are posting big moves after the bell on June 26. jesserpound I appreciate your reporting after hours stock moves, but sometimes its misleading if you don't also mention the days miyves for those stocks. Example while riot and overstock did drop significantly after hours, those drops were only a fraction of the days gains.
La source: CNBC - 🏆 12. / 72 Lire la suite »
Stocks edge up, dollar dips with G20 in focusStocks posted modest gains on Friday and the dollar dipped ahead of a meeting on... Wow.. Hall of famer Dilip Patel is still down there
La source: Reuters - 🏆 2. / 97 Lire la suite »
The 10 Top-Performing Stocks Of 2019Take a look at the ten stocks that have shown the greatest returns this year to date. Interesantisimo... 10 of the best performing stocks.🇺🇸🧐☺️💜💋
La source: Forbes - 🏆 394. / 53 Lire la suite »
Cannabis stocks rally with Aleafia leading the charge after a capital raiseCannabis stocks rose Thursday, led by Aleafia Health Inc., which rallied after announcing the closure of a $40. 25 million convertible debt offering that...
La source: MarketWatch - 🏆 3. / 97 Lire la suite »